Novartis AG
Compositions, methods, and therapeutic uses related to fusogenic protein minion
Last updated:
Abstract:
The invention provides novel compositions, methods, and therapeutic uses related to fusogenic protein MINION (microprotein inducer of fusion).
Status:
Grant
Type:
Utility
Filling date:
10 Nov 2017
Issue date:
24 May 2022